Evicenter
P&T meetings

Ulixacaltamide

Essential tremor

Regulatory submission
NDA submitted by February 2026
Launch
Not announced
Last updated
78 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Essential tremor

Economic burden and healthcare resource utilization

2 evidence topics · 3 sources

All-cause and essential tremor-related healthcare costs in 2019 US dollars

“The average all-cause HCC was $17 560 per ET patient per year (PPPY)” (opens the source at this quote in a new tab)

“ET-related HCC accounting for 13% ($2233 PPPY)” (opens the source at this quote in a new tab)

Direct medical costs in 2018-2019

“ET patients aged 40+ had about USD 28,217 in direct medical costs per year” (opens the source at this quote in a new tab)

“USD 1,601 more than matched comparisons (p < 0.001)” (opens the source at this quote in a new tab)